Browse > Article
http://dx.doi.org/10.4062/biomolther.2012.20.1.062

Apigenin Sensitizes Huh-7 Human Hepatocellular Carcinoma Cells to TRAIL-induced Apoptosis  

Kim, Eun-Young (College of Pharmacy, Sookmyung Women's University)
Kim, An-Keun (College of Pharmacy, Sookmyung Women's University)
Publication Information
Biomolecules & Therapeutics / v.20, no.1, 2012 , pp. 62-67 More about this Journal
Abstract
TNF-related apoptosis-inducing ligand (TRAIL) is a promising agent for management of cancer because of its selective cytotoxicity to cancer cells. However, some cancer cells have resistance to TRAIL. Accordingly, novel treatment strategies are required to overcome TRAIL resistance. Here, we examined the synergistic apoptotic effect of apigenin in combination with TRAIL in Huh-7 cells. We found that combined treatment of TRAIL and apigenin markedly inhibited Huh-7 cell growth compared to either agent alone by inducing apoptosis. Combined treatment with apigenin and TRAIL induced chromatin condensation and the cleavage of poly (ADP-ribose) polymerase (PARP). In addition, enhanced apoptosis by TRAIL/apigenin combination was quantified by annexin V/PI flow cytometry analysis. Western blot analysis suggested that apigenin sensitizes cells to TRAIL-induced apoptosis by activating both intrinsic and extrinsic apoptotic pathway-related caspases. The augmented apoptotic effect by TRAIL/apigenin combination was accompanied by triggering mitochondria-dependent signaling pathway, as indicated by Bax/Bcl-2 ratio up-regulation. Our results demonstrate that combination of TRAIL and apigenin facilitates apoptosis in Huh-7 cells.
Keywords
TRAIL; Huh-7; Combination; Apoptosis; Caspase family; Bcl-2 family;
Citations & Related Records
 (Related Records In Web of Science)
Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Adams, J. M. and Cory, S. (2007) The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene. 26, 1324-1337.   DOI   ScienceOn
2 Andrzejewski, T., Deeb, D., Gao, X., Danyluk, A., Arbab, A. S., Dulchavsky, S. A. and Gautam, S. C. (2008) Therapeutic effi cacy of curcumin/TRAIL combination regimen for hormone-refractory prostate cancer. Oncol. Res. 17, 257-267.   DOI   ScienceOn
3 Armeanu, S., Lauer, U. M., Smirnow, I., Schenk, M., Weiss, T. S., Gregor, M. and Bitzer, M. (2003) Adenoviral gene transfer of tumor necrosis factor-related apoptosis-inducing ligand overcomes an impaired response of hepatoma cells but causes severe apoptosis in primary human hepatocytes. Cancer Res. 63, 2369-2372.
4 Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang, L., McMurtrey, A. E., Hebert, A., DeForge, L., Koumenis, I. L., Lewis, D., Harris, L., Bussiere, J., Koeppen, H., Shahrokh, Z. and Schwall, R. H. (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Invest. 104, 155-162.   DOI   ScienceOn
5 Bhojani, M. S., Rossú, B. D. and Rehemtulla, A. (2003) TRAIL and anti-tumor responses. Cancer Biol. Ther. 2 (4 Suppl 1), S71-S78.
6 Birt, D. F., Mitchell, D., Gold, B., Pour, P. and Pinch, H. C. (1997) Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. Anticancer. Res. 17, 85-91.
7 Chiang, L. C., Ng, L. T., Lin, I. C., Kuo, P. L. and Lin, C. C. (2006) Antiproliferative effect of apigenin and its apoptotic induction in human Hep G2 cells. Cancer Lett. 237, 207-214.   DOI   ScienceOn
8 Cohen, G. M. (1997) Caspases: the executioners of apoptosis. Biochem. J. 326, 1-16.
9 Deeb, D., Jiang, H., Gao, X., Hafner, M. S, Wong, H., Divine, G., Chapman, R. A., Dulchavsky, S. A. and Gautam, S. C. (2004) Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-${\kappa}B$through suppression of I${\kappa}B{\alpha}$ phosphorylation. Mol. Cancer Ther. 3, 803-812.
10 Eggert, A., Grotzer, M. A., Zuzak, T. J., Wiewrodt, B. R., Ho, R., Ikegaki, N. and Brodeur, G. M. (2001) Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. Cancer Res. 61, 1314-1319.
11 Gross, A., McDonnell, J. M. and Korsmeyer, S. J. (1999) BCL-2 family members and the mitochondria in apoptosis. Genes. Dev. 13, 1899-1911.   DOI   ScienceOn
12 Gupta, S., Afaq, F. and Mukhtar, H. (2001) Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells. Biochem. Biophys. Res. Commun. 287, 914-920.   DOI   ScienceOn
13 Hao, C., Song, J. H., Hsi, B., Lewis, J., Song, D. K., Petruk, K. C., Tyrrell, D. L. and Kneteman, N. M. (2004) TRAIL inhibits tumor growth but is nontoxic to human hepatocytes in chimeric mice. Cancer Res. 64, 8502-8506.   DOI   ScienceOn
14 Higashitsuji, H., Higashitsuji, H., Masuda, T., Liu, Y., Itoh, K. and Fujita, J. (2007) Enhanced deacetylation of p53 by the anti-apoptotic protein HSCO in association with histone deacetylase 1. J. Biol. Chem. 282, 13716-13725.   DOI
15 Hinz, S., Trauzold, A., Boenicke, L., Sandberg, C., Beckmann, S., Bayer, E., Walczak, H., Kalthoff, H. and Ungefroren, H. (2000) Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis. Oncogene. 19, 5477-5486.   DOI   ScienceOn
16 Jacquemin, G., Shirley, S. and Micheau, O. (2010) Combining naturally occurring polyphenols with TNF-related apoptosis-inducing ligand: a promising approach to kill resistant cancer cells? Cell Mol. Life Sci. 67, 3115-3130.   DOI   ScienceOn
17 Johnstone, R. W., Ruefl i, A. A. and Lowe, S. W. (2002) Apoptosis: a link between cancer genetics and chemotherapy. Cell. 108, 153-164.   DOI   ScienceOn
18 Koschny, R., Ganten, T. M., Sykora, J., Haas, T. L., Sprick, M. R., Kolb, A., Stremmel, W. and Walczak, H. (2007) TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer-specifi c apoptosis within a therapeutic window. Hepatology. 45, 649-658.   DOI   ScienceOn
19 Jung, E. M., Lim, J. H., Lee, T. J., Park, J. W., Choi, K. S. and Kwon, T. K. (2005) Curcumin sensitizes tumor necrosis factor-related apoptosis- inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5). Carcinogenesis. 26, 1905-1913.   DOI   ScienceOn
20 Kim, D. S., Jeong, Y. M., Moon, S. I., Kim, S. Y., Kwon, S. B., Park, E. S., Youn, S. W. and Park, K. C. (2006) Indole-3-carbinol enhances ultraviolet B-induced apoptosis by sensitizing human melanoma cells. Cell Mol. Life Sci. 63, 2661-2668.   DOI   ScienceOn
21 Kruyt, F. A. (2008) TRAIL and cancer therapy. Cancer Lett. 263, 14-25.   DOI   ScienceOn
22 Lawrence, D., Shahrokh, Z., Marsters, S., Achilles K,, Shih, D., Mounho, B., Hillan, K., Totpal, K., DeForge, L., Schow, P., Hooley, J., Sherwood, S., Pai, R., Leung, S., Khan, L., Gliniak, B., Bussiere, J., Smith, C. A., Strom, S. S., Kelley, S., Fox, J. A., Thomas, D. and Ashkenazi, A. (2001) Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions. Nat. Med. 7, 383-385.   DOI   ScienceOn
23 Moll, U. M. and Zaika, A. (2001) Nuclear and mitochondrial apoptotic pathways of p53. FEBS. Lett. 493, 65-69.   DOI   ScienceOn
24 Nitsch, R., Bechmann, I., Deisz, R. A., Haas, D., Lehmann, T. N., Wendling, U., and Zipp, F. (2000) Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL). Lancet. 356, 827-828.   DOI   ScienceOn
25 Roth, W., Isenmann, S., Naumann, U., Kugler, S., Bähr, M., Dichgans, J., Ashkenazi, A. and Weller, M. (1999) Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity. Biochem. Biophys. Res. Commun. 265, 479-483.   DOI   ScienceOn
26 Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffi th, T.S., Kubin, M., Chin, W., Jones J, Woodward, A., Le, T., Smith, C., Smolak, P., Goodwin, R. G., Rauch, C. T., Schuh J, C. and Lynch, D. H. (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med. 5, 157-163.   DOI   ScienceOn
27 Siegelin, M. D., Reuss, D. E., Habel, A., Herold-Mende, C. and von Deimling, A. (2008) The flavonoid kaempferol sensitizes human glioma cells to TRAIL-mediated apoptosis by proteasomal degradation of survivin. Mol. Cancer Ther. 7, 3566-3574.   DOI   ScienceOn
28 Sun, X. M., MacFarlane, M., Zhuang, J., Wolf, B. B., Green, D. R. and Cohen, G. M. (1999) Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J. Biol. Chem. 274, 5053-5060.   DOI   ScienceOn
29 Van Geelen, C. M., de Vries, E. G. and de Jong, S. (2004) Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy. Drug Resist. Updat. 7, 345-358.   DOI   ScienceOn
30 Wang, W., Heideman, L., Chung, C. S., Pelling, J. C., Koehler, K. J. and Birt, D. F. (2000) Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Mol. Carcinog. 28, 102-110.   DOI   ScienceOn
31 Way, T. D., Kao, M. C. and Lin, J. K. (2003) Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neuoverexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway. J. Biol. Chem. 279, 4479-4489.   DOI
32 Wei, H., Tye, L., Bresnick, E. and Birt, D. F. (1990) Inhibitory effect of apigenin, a plant fl avonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res. 50, 499-502.
33 Wolf, B. B. and Green, D. R. (1999) Suicidal tendencies: apoptotic cell death by caspase family proteinases. J. Biol. Chem. 274, 20049-20052.   DOI
34 Zhang, Y. and Zhang, B. (2008) TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5. Mol. Cancer Res. 6, 1861-1871.   DOI   ScienceOn
35 Yano, Y., Hayashi, Y., Nakaji, M., Nagano, H., Seo, Y., Ninomiya, T., Yoon, S., Wada, A., Hirai, M., Kim, S. R., Yokozaki, H. and Kasuga, M. (2003) Different apoptotic regulation of TRAIL-caspase pathway in HBV- and HCV-related hepatocellular carcinoma. Int. J. Mol. Med. 11, 499-504.
36 Yoshida, T., Konishi, M., Horinaka, M., Yasuda, T., Goda, A. E., Taniguchi, H., Yano, K., Wakada, M. and Sakai, T. (2008) Kaempferol sensitizes colon cancer cells to TRAIL-induced apoptosis. Biochem. Biophys. Res. Commun. 375, 129-133.   DOI   ScienceOn
37 Zhang, L. and Fang, B. (2005) Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Cancer Gene Ther. 12, 228-237.   DOI   ScienceOn